{"id":2353,"date":"2022-01-03T14:14:00","date_gmt":"2022-01-03T13:14:00","guid":{"rendered":"http:\/\/grupo.us.es\/healthterritory\/?p=2353"},"modified":"2022-01-03T14:14:00","modified_gmt":"2022-01-03T13:14:00","slug":"14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2","status":"publish","type":"post","link":"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/","title":{"rendered":"14\/04\/2021 The results of the first phase of REUMAVID have been presented at the British Society for Rheumatology Annual Conference (BSR 2021)"},"content":{"rendered":"

The results of the first phase of REUMAVID have been presented at the British Society for Rheumatology Annual Conference (BSR 2021).<\/h2>\n

The results of the first phase of the REUMAVID study were presented on Monday 14 April 2021 at the British Society for Rheumatology Annual Conference (BSR 2021).<\/p>\n

The interest in the study has led to it being selected for several activities: an ePoster presenting the study data for the UK sample (\u00abEvaluation of the Impact of the COVID-19 Pandemic on Patients with Rheumatic Diseases in the UK: Results from the REUMAVID Study\u00bb) and a panel session on REUMAVID presented by Prof. Marco Garrido-Cumbrera. Marco Garrido-Cumbrera from Health & Territory Research (HTR), Dr Helena Marzo-Ortega from Leeds University Hospital and Dr Dale Webb from the National Ankylosing Spondylitis Society (NASS), with Dr Victoria Navarro-Comp\u00e1n as chair.<\/p>\n

The speakers will present to the UK medical community the objectives, methodology and main results of the study at national and international level, as well as one of the main conclusions of REUMAVID: the relevant role of patient organisations in patient advocacy during the pandemic.<\/p>\n","protected":false},"excerpt":{"rendered":"

The results of the first phase of REUMAVID have been presented at the British Society for Rheumatology Annual Conference (BSR 2021). The results of the first phase of the REUMAVID study were presented on Monday 14 April 2021 at the British Society for Rheumatology Annual Conference (BSR 2021). The interest in the study has led…<\/p>\n","protected":false},"author":7,"featured_media":2136,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2353","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-1","description-off"],"yoast_head":"\n14\/04\/2021 The results of the first phase of REUMAVID have been presented at the British Society for Rheumatology Annual Conference (BSR 2021) - Health & Territory Research<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"14\/04\/2021 The results of the first phase of REUMAVID have been presented at the British Society for Rheumatology Annual Conference (BSR 2021) - Health & Territory Research\" \/>\n<meta property=\"og:description\" content=\"The results of the first phase of REUMAVID have been presented at the British Society for Rheumatology Annual Conference (BSR 2021). The results of the first phase of the REUMAVID study were presented on Monday 14 April 2021 at the British Society for Rheumatology Annual Conference (BSR 2021). The interest in the study has led…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Health & Territory Research\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-03T13:14:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/grupo.us.es\/newthterritory\/wp-content\/uploads\/2021\/05\/BSR-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"351\" \/>\n\t<meta property=\"og:image:height\" content=\"203\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Jos\u00e9 Correa Fern\u00e1ndez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jos\u00e9 Correa Fern\u00e1ndez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/\",\"url\":\"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/\",\"name\":\"14\/04\/2021 The results of the first phase of REUMAVID have been presented at the British Society for Rheumatology Annual Conference (BSR 2021) - Health & Territory Research\",\"isPartOf\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2021\/05\/BSR-2.jpg\",\"datePublished\":\"2022-01-03T13:14:00+00:00\",\"author\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/#\/schema\/person\/6edfd257e38aaa36b2d51b61392dfb7b\"},\"breadcrumb\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/#primaryimage\",\"url\":\"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2021\/05\/BSR-2.jpg\",\"contentUrl\":\"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2021\/05\/BSR-2.jpg\",\"width\":351,\"height\":203},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/grupo.us.es\/newthterritory\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"14\/04\/2021 The results of the first phase of REUMAVID have been presented at the British Society for Rheumatology Annual Conference (BSR 2021)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/#website\",\"url\":\"https:\/\/grupo.us.es\/healthterritory\/\",\"name\":\"Health & Territory Research\",\"description\":\"Interdisciplinary Research Group of the University of Seville\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/grupo.us.es\/healthterritory\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/#\/schema\/person\/6edfd257e38aaa36b2d51b61392dfb7b\",\"name\":\"Jos\u00e9 Correa Fern\u00e1ndez\",\"sameAs\":[\"http:\/\/grupo.us.es\/healthterritory\/\"],\"url\":\"https:\/\/grupo.us.es\/healthterritory\/author\/pepe\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"14\/04\/2021 The results of the first phase of REUMAVID have been presented at the British Society for Rheumatology Annual Conference (BSR 2021) - Health & Territory Research","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/","og_locale":"es_ES","og_type":"article","og_title":"14\/04\/2021 The results of the first phase of REUMAVID have been presented at the British Society for Rheumatology Annual Conference (BSR 2021) - Health & Territory Research","og_description":"The results of the first phase of REUMAVID have been presented at the British Society for Rheumatology Annual Conference (BSR 2021). The results of the first phase of the REUMAVID study were presented on Monday 14 April 2021 at the British Society for Rheumatology Annual Conference (BSR 2021). The interest in the study has led…","og_url":"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/","og_site_name":"Health & Territory Research","article_published_time":"2022-01-03T13:14:00+00:00","og_image":[{"width":351,"height":203,"url":"https:\/\/grupo.us.es\/newthterritory\/wp-content\/uploads\/2021\/05\/BSR-2.jpg","type":"image\/jpeg"}],"author":"Jos\u00e9 Correa Fern\u00e1ndez","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Jos\u00e9 Correa Fern\u00e1ndez","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/","url":"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/","name":"14\/04\/2021 The results of the first phase of REUMAVID have been presented at the British Society for Rheumatology Annual Conference (BSR 2021) - Health & Territory Research","isPartOf":{"@id":"https:\/\/grupo.us.es\/healthterritory\/#website"},"primaryImageOfPage":{"@id":"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/#primaryimage"},"image":{"@id":"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/#primaryimage"},"thumbnailUrl":"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2021\/05\/BSR-2.jpg","datePublished":"2022-01-03T13:14:00+00:00","author":{"@id":"https:\/\/grupo.us.es\/healthterritory\/#\/schema\/person\/6edfd257e38aaa36b2d51b61392dfb7b"},"breadcrumb":{"@id":"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/#primaryimage","url":"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2021\/05\/BSR-2.jpg","contentUrl":"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2021\/05\/BSR-2.jpg","width":351,"height":203},{"@type":"BreadcrumbList","@id":"https:\/\/grupo.us.es\/healthterritory\/en\/14-04-2021-los-resultados-de-la-primera-fase-de-reumavid-han-sido-presentados-en-the-annual-conference-of-the-british-society-of-rheumatology-bsr-2021-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/grupo.us.es\/newthterritory\/"},{"@type":"ListItem","position":2,"name":"14\/04\/2021 The results of the first phase of REUMAVID have been presented at the British Society for Rheumatology Annual Conference (BSR 2021)"}]},{"@type":"WebSite","@id":"https:\/\/grupo.us.es\/healthterritory\/#website","url":"https:\/\/grupo.us.es\/healthterritory\/","name":"Health & Territory Research","description":"Interdisciplinary Research Group of the University of Seville","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/grupo.us.es\/healthterritory\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/grupo.us.es\/healthterritory\/#\/schema\/person\/6edfd257e38aaa36b2d51b61392dfb7b","name":"Jos\u00e9 Correa Fern\u00e1ndez","sameAs":["http:\/\/grupo.us.es\/healthterritory\/"],"url":"https:\/\/grupo.us.es\/healthterritory\/author\/pepe\/"}]}},"wps_subtitle":"","_links":{"self":[{"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/posts\/2353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/comments?post=2353"}],"version-history":[{"count":1,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/posts\/2353\/revisions"}],"predecessor-version":[{"id":2354,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/posts\/2353\/revisions\/2354"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/media\/2136"}],"wp:attachment":[{"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/media?parent=2353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/categories?post=2353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/tags?post=2353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}